GO:0070378 positive regulation of ERK5 cascade: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070378 describes any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK5 cascade.
• The ERK5 cascade is a MAPK pathway in which MEKK3 activates MEK5, which in turn phosphorylates and activates ERK5 (also known as MAPK7 or BMK1).
• Positive regulation of ERK5 signaling controls diverse cellular outcomes including mitochondrial degradation, monocytic differentiation, osmotic stress responses, and T lymphocyte survival.
• Dysregulated ERK5 cascade activity has been implicated in cancer, cardiovascular disease, and immune cell biology.
• Key experimental approaches to study this process include knockout and point-mutation cell models, phospho-ERK5 immunoblotting, and transcriptomic profiling.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of ERK5 cascade components in disease-relevant cell types.
Description
The Gene Ontology term GO:0070378, positive regulation of ERK5 cascade, refers to any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK5 cascade. The ERK5 cascade is a conserved mitogen-activated protein kinase (MAPK) pathway in which the upstream kinase MEKK3 phosphorylates and activates MEK5, which then phosphorylates ERK5 (also called MAPK7 or BMK1) on specific residues, leading to its nuclear translocation and activation of downstream transcription factors. This pathway is distinct from the classical ERK1/2 cascade and plays unique roles in development, stress responses, and cell survival. Researchers study positive regulation of ERK5 cascade because it integrates diverse extracellular signals into transcriptional programs that control cell fate decisions. For example, MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation during specific cellular contexts, while ERK5 pathway activity regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells. Activation of ERK5 also downregulates FasL upon osmotic stress, linking this pathway to stress-induced apoptosis regulation. In T lymphocytes, an alternative mode of CD43 signal transduction activates pro-survival pathways that include ERK5. Dysregulation of positive regulation of ERK5 cascade has been associated with pathological conditions such as neointima formation in vein grafts, where FSP-1 silencing in bone marrow cells suppresses neointima formation, and with radiation responses where fractionated radiation suppresses the Kruppel-like factor 2 pathway. In breast cancer cells, prolonged ERK1/2 activation during growth factor-induced antiestrogen resistance is resistant to MEK inhibitors, highlighting the complexity of MAPK signaling crosstalk. Understanding how the ERK5 cascade is positively regulated therefore has broad implications for cancer biology, immunology, and cardiovascular research.
positive regulation of ERK5 cascade At A Glance
| GO ID | GO:0070378 |
|---|---|
| GO term | positive regulation of ERK5 cascade |
| Ontology | biological_process |
| Synonym | activation of BMK cascade; positive regulation of BMK1 cascade; positive regulation of BMK cascade; positive regulation of BMK signaling pathway; positive regulation of BMK signalling pathway; positive regulation of ERK5 signaling pathway; positive regulation of MAPK7 cascade; stimulation of BMK cascade; up regulation of BMK cascade; up-regulation of BMK cascade; upregulation of BMK cascade |
| Major function | Activates or increases the frequency, rate or extent of signal transduction mediated by the ERK5 cascade |
| Upstream regulators | MEKK3, MEK5 |
| Core kinase | ERK5 (MAPK7/BMK1) |
| Downstream effectors | Transcription factors such as MEF2, c-Fos, and others depending on cell context |
| Related terms | ERK5 cascade (GO:0070377); negative regulation of ERK5 cascade (GO:0070379) |
What Is GO:0070378?
In my own words, GO:0070378 positive regulation of ERK5 cascade encompasses any molecular event or cellular process that increases the activity, frequency, rate, or extent of the signaling pathway mediated by ERK5 (MAPK7/BMK1). This includes upstream activation of MEKK3 and MEK5, phosphorylation of ERK5, enhancement of ERK5 nuclear localization, and increased transcription of ERK5 target genes. The term is a biological process and is distinct from the ERK5 cascade itself (GO:0070377) and from negative regulation of ERK5 cascade (GO:0070379).
Why Is positive regulation of ERK5 cascade Important in Cell Biology?
Positive regulation of ERK5 cascade is critically important because the ERK5 pathway is a major MAPK signaling axis that controls cell proliferation, differentiation, survival, and stress responses. Unlike the classical ERK1/2 pathway, ERK5 has a unique C-terminal transactivation domain and can directly regulate transcription factors, making it a key integrator of extracellular signals into gene expression programs. Dysregulation of this pathway contributes to cancer progression, cardiovascular remodeling, and immune dysfunction, and it represents a potential therapeutic target.
• Controls mitochondrial degradation through MEKK3-MEK5-ERK5 signaling.
• Regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.
• Mediates downregulation of FasL upon osmotic stress, influencing apoptosis.
• Suppresses neointima formation in vein grafts when FSP-1 is silenced in bone marrow cells.
• Is suppressed by fractionated radiation, affecting Kruppel-like factor 2 pathway.
• Activates pro-survival pathways in T lymphocytes via CD43 signal transduction.
• Contributes to antiestrogen-resistant growth in breast cancer cells through prolonged MAPK activation.
• Serves as a potential target for therapeutic intervention in cancer and cardiovascular disease.
• Provides a mechanism for crosstalk between stress signals and transcriptional programs.
• Enables researchers to dissect cell-fate decisions using CRISPR-based models.
What Happens During positive regulation of ERK5 cascade?
Upstream activation of MEKK3 and MEK5
In simple terms: First, proteins upstream in the pathway turn on the kinases that will eventually activate ERK5.
Positive regulation of the ERK5 cascade typically begins with activation of MEKK3, a MAP3K that phosphorylates and activates MEK5. MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation, demonstrating that this upstream module is essential for initiating the cascade. In some contexts, alternative receptors such as CD43 can trigger pro-survival pathways that include ERK5 activation in T lymphocytes.
Phosphorylation and activation of ERK5
In simple terms: MEK5 adds phosphate groups to ERK5, switching it on.
Activated MEK5 phosphorylates ERK5 (MAPK7/BMK1) on specific threonine and tyrosine residues, leading to ERK5 kinase activation. This phosphorylation event is a hallmark of positive regulation of the ERK5 cascade and is required for downstream signaling. Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress, showing that ERK5 phosphorylation is functionally linked to stress responses.
Nuclear translocation and transcription factor regulation
In simple terms: Activated ERK5 moves into the nucleus and turns on specific genes.
Once activated, ERK5 translocates to the nucleus where it regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells. ERK5 pathway activity also influences transcription factors that control cell cycle and survival genes, thereby shaping cell fate decisions. This nuclear function distinguishes ERK5 from many other MAPKs and underscores its role in gene expression.
Crosstalk with other signaling pathways
In simple terms: The ERK5 cascade talks to other signaling pathways to fine-tune responses.
Positive regulation of ERK5 cascade can intersect with ERK1/2 signaling. For example, prolonged ERK1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to MEK inhibitors, indicating complex crosstalk between MAPK pathways. Fractionated radiation suppresses the Kruppel-like factor 2 pathway to a greater extent than single exposure, suggesting that ERK5 signaling may be modulated by DNA damage responses.
Physiological outcomes: survival, differentiation, and stress responses
In simple terms: The final result is changes in cell behavior such as survival, differentiation, or stress handling.
Depending on cell type, positive regulation of ERK5 cascade can promote mitochondrial degradation, drive monocytic differentiation, downregulate FasL under osmotic stress, suppress neointima formation in vein grafts, or activate pro-survival pathways in T lymphocytes. These diverse outcomes highlight the context-dependent nature of ERK5 signaling.
Key Genes Involved in GO:0070378 positive regulation of ERK5 cascade
The following genes and proteins are central to positive regulation of ERK5 cascade, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MEKK3 (MAP3K3) | Upstream MAP3K that activates MEK5 | Initiates ERK5 cascade; studied in mitochondrial degradation |
| MEK5 (MAP2K5) | MAP2K that phosphorylates ERK5 | Essential for ERK5 activation; target for pathway inhibition |
| ERK5 (MAPK7/BMK1) | Core kinase of the cascade | Central to signaling; regulates transcription factors and stress responses |
| FSP-1 (S100A4) | Modulates neointima formation | Silencing in bone marrow cells suppresses neointima formation |
| KLF2 | Transcription factor suppressed by radiation | Linked to fractionated radiation responses |
| CD43 | T cell surface receptor | Activates pro-survival pathways including ERK5 in T lymphocytes |
| FGFR1 | Receptor for FGF1 | Induces prolonged ERK1/2 activation in breast cancer cells |
| ERBB3 (HER3) | Receptor for heregulin beta1 | Induces antiestrogen-resistant growth via MAPK pathways |
| MEF2 | Transcription factor downstream of ERK5 | Regulates differentiation and survival genes |
| c-Fos | Immediate early transcription factor | Target of ERK5 signaling in differentiation |
| c-Jun | AP-1 transcription factor | Modulated by ERK5 pathway in stress responses |
| FasL | Apoptosis-inducing ligand | Downregulated by ERK5 upon osmotic stress |
| MAPK1 (ERK2) | Classical MAPK | Crosstalk with ERK5 pathway |
| MAPK3 (ERK1) | Classical MAPK | Crosstalk with ERK5 pathway |
| SP1 | Transcription factor | Potential downstream effector of ERK5 |
| NF-kB | Transcription factor | Modulated by ERK5 signaling in immune cells |
| STAT3 | Transcription factor | Linked to pro-survival pathways in T lymphocytes |
How Is positive regulation of ERK5 cascade Regulated?
Positive regulation of ERK5 cascade is itself regulated at multiple levels. Upstream, MEKK3 and MEK5 activity is controlled by growth factor receptors, stress signals, and G-protein coupled receptors. Phosphatases such as DUSP family members can dephosphorylate ERK5 and terminate signaling, providing negative feedback. Additionally, crosstalk with ERK1/2 and other MAPK pathways can modulate the strength and duration of ERK5 activation. In T lymphocytes, CD43 engagement activates pro-survival pathways that include ERK5, showing that immune receptor signaling can positively regulate this cascade. Fractionated radiation suppresses KLF2 pathway, suggesting that DNA damage responses may also influence ERK5 activity.
positive regulation of ERK5 cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ERK5 (MAPK7) | Cancer, cardiovascular disease | Knockout and point-mutation cell lines |
| MEKK3 (MAP3K3) | Mitochondrial degradation, cancer | Knockout models to block ERK5 activation |
| FSP-1 (S100A4) | Neointima formation | Bone marrow cell silencing and vein graft models |
| CD43 | T cell survival, immune disorders | T lymphocyte knockout and overexpression |
| KLF2 | Radiation response | Fractionated radiation cell models |
Cancer and therapy resistance
Dysregulated positive regulation of ERK5 cascade has been implicated in cancer. Prolonged ERK1/2 activation during FGF1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to MEK inhibitors, indicating that MAPK pathway crosstalk, including ERK5, may contribute to therapy resistance. ERK5 pathway activity also regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells, suggesting a role in leukemia cell fate.
Cardiovascular disease
FSP-1 silencing in bone marrow cells suppresses neointima formation in vein graft, a process that may involve ERK5 signaling. This suggests that positive regulation of ERK5 cascade could be a therapeutic target for preventing vascular remodeling after bypass surgery.
Immune and inflammatory responses
In T lymphocytes, an alternative mode of CD43 signal transduction activates pro-survival pathways that include ERK5, linking this cascade to immune cell survival and function. Activation of ERK5 also downregulates FasL upon osmotic stress, which may affect apoptosis and immune privilege.
Radiation and stress responses
Fractionated radiation suppresses the Kruppel-like factor 2 pathway to a greater extent than single exposure to the same total dose, indicating that ERK5 signaling may be modulated by radiation-induced stress. This has implications for radiotherapy and tissue injury.
From positive regulation of ERK5 cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MEKK3 loss block ERK5 activation? | MEKK3 knockout cell line |
| Does ERK5 point mutation affect downstream transcription? | ERK5 point-mutation knock-in |
| Can ERK5 overexpression drive differentiation? | ERK5 overexpression cell model |
| Does FSP-1 silencing suppress neointima formation? | Bone marrow FSP-1 knockout |
| How does CD43 activate ERK5 in T cells? | CD43 knockout and knock-in T lymphocytes |
| Does fractionated radiation alter ERK5 signaling? | Radiation-treated cell lines with ERK5 reporters |
How to Study the positive regulation of ERK5 cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-ERK5 immunoblotting | ERK5 activation status | Pathway activation in cell lines |
| RNA-seq | Transcriptional changes | Downstream target identification |
| CRISPR knockout screens | Gene essentiality for ERK5 signaling | Novel regulator discovery |
| Immunofluorescence | ERK5 subcellular localization | Nuclear translocation studies |
| Co-immunoprecipitation | Protein-protein interactions | MEK5-ERK5 complex formation |
| Luciferase reporter assays | Transcription factor activity | MEF2, c-Fos regulation |
| Flow cytometry | Cell differentiation and survival | Monocytic differentiation |
| Mass spectrometry | Phosphoproteomics | Global ERK5 substrate identification |
Phospho-ERK5 immunoblotting
Western blotting with phospho-specific ERK5 antibodies is the standard method to measure activation of the ERK5 cascade. This approach has been used to show MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation and that ERK5 is activated upon osmotic stress.
Transcriptomic profiling
RNA-seq or microarray analysis can identify downstream transcriptional programs regulated by positive regulation of ERK5 cascade. For example, ERK5 pathway activity regulates transcription factors important for monocytic differentiation, which can be assessed by gene expression profiling.
CRISPR-based genetic screens
Pooled CRISPR knockout screens can identify genes that positively or negatively regulate ERK5 cascade activity. This is particularly useful for discovering novel regulators of the pathway in cancer or immune cells.
Imaging and subcellular localization
Fluorescence microscopy with GFP-tagged ERK5 can track nuclear translocation, a key step in positive regulation of ERK5 cascade. This method has been used to study ERK5 dynamics in various cell types.
How CRISPR Can Be Used to Study GO:0070378 positive regulation of ERK5 cascade
Knockout
CRISPR knockout of MEKK3, MEK5, or ERK5 can abolish positive regulation of ERK5 cascade, providing causal evidence for their roles. For example, MEKK3 knockout blocks mitochondrial degradation. Knockout of FSP-1 in bone marrow cells suppresses neointima formation.
Point Mutation
Point mutations in ERK5 phosphorylation sites or in MEK5 catalytic residues can dissect the requirement for specific phosphorylation events. Such models help distinguish ERK5-dependent from ERK5-independent functions.
Knock-in
Knock-in of tagged ERK5 (e.g., GFP or HA) allows real-time tracking of ERK5 localization and interaction partners. This is valuable for studying nuclear translocation and transcription factor regulation.
Overexpression
Overexpression of constitutively active MEK5 or ERK5 can drive the cascade in the absence of upstream signals, enabling gain-of-function studies. This approach has been used to study monocytic differentiation and survival pathways.
How EDITGENE Supports positive regulation of ERK5 cascade Research
Researchers studying positive regulation of ERK5 cascade-related genes often need to determine whether a candidate gene is causally involved in pathway activation, downstream transcription, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of ERK5 cascade research.
Frequently Asked Questions About positive regulation of ERK5 cascade
What is positive regulation of ERK5 cascade?
It is any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK5 cascade, as defined by GO:0070378.
What genes are involved in positive regulation of ERK5 cascade?
Key genes include MEKK3, MEK5, ERK5 (MAPK7/BMK1), and downstream transcription factors such as MEF2 and c-Fos.
How is ERK5 activated?
MEKK3 activates MEK5, which phosphorylates ERK5 on specific residues, leading to its activation and nuclear translocation.
What diseases are linked to ERK5 signaling?
ERK5 signaling has been implicated in cancer, cardiovascular disease, immune disorders, and radiation responses.
What is the difference between ERK5 and ERK1/2?
ERK5 is a distinct MAPK with a unique C-terminal transactivation domain, while ERK1/2 are classical MAPKs; crosstalk between them occurs.
How can I study positive regulation of ERK5 cascade?
Common methods include phospho-ERK5 immunoblotting, RNA-seq, CRISPR knockout screens, and immunofluorescence.
What cell models are available for ERK5 research?
Knockout, point-mutation, knock-in, and overexpression models can be generated using CRISPR technology.
Does ERK5 signaling affect mitochondrial function?
Yes, MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation.
Is ERK5 involved in T cell survival?
Yes, CD43 signal transduction activates pro-survival pathways including ERK5 in T lymphocytes.
How does radiation affect ERK5 signaling?
Fractionated radiation suppresses the Kruppel-like factor 2 pathway, which may involve ERK5 modulation.
Conclusion
Positive regulation of ERK5 cascade (GO:0070378) is a critical biological process that controls diverse cellular outcomes through the MEKK3-MEK5-ERK5 signaling axis. Its dysregulation contributes to cancer, cardiovascular disease, and immune dysfunction, making it an important research focus. CRISPR-based models and advanced omics technologies are essential tools for dissecting this pathway and identifying therapeutic targets. EDITGENE provides comprehensive services to support these efforts.
References
- 1. Craig JE et al.. 2020. MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation.. Cell Death Discov 6:107 PMID: 33101709
- 2. Wang X et al.. 2014. ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.. J Cell Physiol 229(7):856-67 PMID: 24264602
- 3. Wang X et al.. 2006. Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress.. Cell Death Differ 13(12):2099-108 PMID: 16710360
- 4. Cheng J et al.. 2012. FSP-1 silencing in bone marrow cells suppresses neointima formation in vein graft.. Circ Res 110(2):230-40 PMID: 22116816
- 5. Sadhukhan R et al.. 2020. Fractionated radiation suppresses Kruppel-like factor 2 pathway to a greater extent than by single exposure to the same total dose.. Sci Rep 10(1):7734 PMID: 32382091
- 6. Bravo-Adame ME et al.. 2017. An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.. Immunology 150(1):87-99 PMID: 27606486
- 7. Thottassery JV et al.. 2004. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.. Cancer Res 64(13):4637-47 PMID: 15231676
